Status:

COMPLETED

Integrated Infectious Disease Capacity-Building Evaluation

Lead Sponsor:

University of Washington

Collaborating Sponsors:

Makerere University

Accordia Global Health Foundation

Conditions:

Capacity Building

Support for Midlevel Health Professionals

Eligibility:

All Genders

Phase:

NA

Brief Summary

This evaluation aim is to investigate a cost-effective way to build capacity for the care and prevention of infectious diseases among mid-level practitioners (MLP) in sub-Saharan Africa. Classroom bas...

Detailed Description

There are four major components of the evaluation design as described below: 1) Site Assessment, 2) Competence and practice of individual MLP who participate in IDT, 3) Facility cost and performance i...

Eligibility Criteria

Inclusion

  • Facilities selected for OSS:
  • The health facility had to be a HC IV or comparable facility such as a small general hospital or non-governmental organization clinic
  • It had to be an active ART site or accredited ART site that is scheduled to become active by April 2009
  • No past or current participation in a partnership with the U.S. Department of Defense
  • Has a population of potential patients who are not prisoners
  • Representation from all six administrative regions of Uganda

Exclusion

  • NA
  • MLP selected from the participating facilities for IMID:
  • Two mid-level practitioners (clinical officers, nurses, or midwives) who are actively engaged in clinical infectious-disease care will be selected for enrollment in IMID

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT01190540

Start Date

November 1 2008

End Date

August 1 2012

Last Update

December 3 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Infectious Disease Institute, Makerere University

Kampala, Uganda

Integrated Infectious Disease Capacity-Building Evaluation | DecenTrialz